These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 33564682

  • 1. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
    Abe Y, Tada K, Yamaji K, Tamura N.
    Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
    Weng MY, Weng CT, Liu MF.
    Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
    [Abstract] [Full Text] [Related]

  • 7. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.
    Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y.
    Mod Rheumatol; 2015 Jul; 25(6):854-7. PubMed ID: 25800636
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 9. Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review.
    Mendoza-Pinto C, Pirone C, van der Windt DA, Parker B, Bruce IN.
    Semin Arthritis Rheum; 2017 Aug; 47(1):65-78. PubMed ID: 28325471
    [Abstract] [Full Text] [Related]

  • 10. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X, Gu F, Chen W, Liu Y, Wei H, Liu L, Yin S, Da Z, Sun L.
    Chin Med J (Engl); 2014 Aug; 127(21):3718-23. PubMed ID: 25382325
    [Abstract] [Full Text] [Related]

  • 11. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
    Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
    Mod Rheumatol; 2015 Aug; 25(6):858-64. PubMed ID: 26215483
    [Abstract] [Full Text] [Related]

  • 12. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis.
    Ohkubo N, Iwata S, Nakano K, Miyagawa I, Hanami K, Fukuyo S, Miyazaki Y, Kawabe A, Nakayamada S, Tanaka Y.
    Mod Rheumatol; 2022 Oct 15; 32(6):1077-1085. PubMed ID: 34915579
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul 15; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Jul 15; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May 15; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M.
    Curr Opin Rheumatol; 2011 Sep 15; 23(5):454-8. PubMed ID: 21720247
    [Abstract] [Full Text] [Related]

  • 18. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul 15; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K, Gladman DD, Su J, Urowitz MB.
    J Rheumatol; 2016 Mar 15; 43(3):552-8. PubMed ID: 26773121
    [Abstract] [Full Text] [Related]

  • 20. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2019 Apr 15; 28(5):613-620. PubMed ID: 30871425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.